Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 350 entries
Sorted by: Best Match Show Resources per page
Why Foucault?: New directions in educational research

educational research

Steinberg S.
GSID: uAmobcaLwm8J
S Steinberg - 2007 - books.google.com

… the educational subject—the pupil , the student, the teacher etc.—in terms of a history of subjectivity and a genealogical investigation that allowed educational … The use and development of Foucault's work is not yet well enough established in...

Cite
Steinberg, S. (2007). Why Foucault?: New directions in educational research (Vol. 292). Peter Lang.
Steinberg, Shirley. Why Foucault?: New directions in educational research. Vol. 292. Peter Lang, 2007.
Copy Download .nbib Format: MLA
A developmental approach to school-based treatment of adolescents exposed to trauma and traumatic loss

community settings

Layne CM, Steinberg AM.
GSID: UUHDT_Q-VE0J
WR Saltzman, AM Steinberg, CM Layne… - Journal of Child and …, 2001 - Springer

Over the past decade, the UCLA Trauma Psychiatry Program has developed a school-based intervention program for children and adolescents who have been exposed to trauma and/or …

Cite
Saltzman, W. R., Steinberg, A. M., Layne, C. M., Aisenberg, E., & Pynoos, R. S. (2001). A developmental approach to school-based treatment of adolescents exposed to trauma and traumatic loss. Journal of Child and Adolescent Group Therapy, 11(2), 43-56.
Saltzman, William R., et al. "A developmental approach to school-based treatment of adolescents exposed to trauma and traumatic loss." Journal of Child and Adolescent Group Therapy 11.2 (2001): 43-56.
Copy Download .nbib Format: MLA
Indigenous knowledges in education: Complexities, dangers, and profound benefits

pedagogy

Steinberg SR.
GSID: _B8dnGS7BqAJ
JL Kincheloe, SR Steinberg - Handbook of critical and …, 2008 - methods.sagepub.com

(Semali & Kincheloe, 1999), I have had an opportunity to speak to a variety of audiences about the topic around North America and the world. Of course, many individuals from …

Cite
Kincheloe, J. L., & Steinberg, S. R. (2008). Indigenous knowledges in education: Complexities, dangers, and profound benefits. Handbook of critical and indigenous methodologies, 135-156.
Kincheloe, Joe L., and Shirley R. Steinberg. "Indigenous knowledges in education: Complexities, dangers, and profound benefits." Handbook of critical and indigenous methodologies (2008): 135-156.
Copy Download .nbib Format: MLA
High-Pressure NiAs-Type Modification of FeN.

Angewandte Chemie (International ed. in English)

Clark WP, Steinberg S, Dronskowski R, McCammon C, Kupenko I, Bykov M, Dubrovinsky L, Akselrud LG, Schwarz U, Niewa R.
PMID: 28517174
Angew Chem Int Ed Engl. 2017 Jun 12;56(25):7302-7306. doi: 10.1002/anie.201702440. Epub 2017 May 18.

The combination of laser-heated diamond anvil cells and synchrotron Mössbauer source spectroscopy were used to investigate high-temperature high-pressure chemical reactions of iron and iron nitride Fe

Cite
Clark WP, Steinberg S, Dronskowski R, et al. High-Pressure NiAs-Type Modification of FeN. Angew Chem Int Ed Engl. 2017;56(25):7302-7306doi: 10.1002/anie.201702440.
Clark, W. P., Steinberg, S., Dronskowski, R., McCammon, C., Kupenko, I., Bykov, M., Dubrovinsky, L., Akselrud, L. G., Schwarz, U., & Niewa, R. (2017). High-Pressure NiAs-Type Modification of FeN. Angewandte Chemie (International ed. in English), 56(25), 7302-7306. https://doi.org/10.1002/anie.201702440
Clark, William P, et al. "High-Pressure NiAs-Type Modification of FeN." Angewandte Chemie (International ed. in English) vol. 56,25 (2017): 7302-7306. doi: https://doi.org/10.1002/anie.201702440
Clark WP, Steinberg S, Dronskowski R, McCammon C, Kupenko I, Bykov M, Dubrovinsky L, Akselrud LG, Schwarz U, Niewa R. High-Pressure NiAs-Type Modification of FeN. Angew Chem Int Ed Engl. 2017 Jun 12;56(25):7302-7306. doi: 10.1002/anie.201702440. Epub 2017 May 18. PMID: 28517174; PMCID: PMC5488211.
Copy Download .nbib Format: NLM
Research projects in the Surgeon-Scientist and Clinician-Investigator programs at the University of Toronto (1987-2016): a cohort study.

CMAJ open

Goldenberg NM, Steinberg BE, Rutka JT, Chen R, Cabral V, Rosenblum ND, Kapus A, Lee WL.
PMID: 27730108
CMAJ Open. 2016 Aug 22;4(3):E444-E447. doi: 10.9778/cmajo.20160062. eCollection 2016.

BACKGROUND: Physicians have traditionally been at the forefront of medical research, bringing clinical questions to the laboratory and returning with ideas for treatment. However, we have anecdotally observed a decline in the popularity of basic science research among trainees....

Cite
Goldenberg NM, Steinberg BE, Rutka JT, et al. Research projects in the Surgeon-Scientist and Clinician-Investigator programs at the University of Toronto (1987-2016): a cohort study. CMAJ Open. 2016;4(3):E444-E447doi: 10.9778/cmajo.20160062.
Goldenberg, N. M., Steinberg, B. E., Rutka, J. T., Chen, R., Cabral, V., Rosenblum, N. D., Kapus, A., & Lee, W. L. (2016). Research projects in the Surgeon-Scientist and Clinician-Investigator programs at the University of Toronto (1987-2016): a cohort study. CMAJ open, 4(3), E444-E447. https://doi.org/10.9778/cmajo.20160062
Goldenberg, Neil M, et al. "Research projects in the Surgeon-Scientist and Clinician-Investigator programs at the University of Toronto (1987-2016): a cohort study." CMAJ open vol. 4,3 (2016): E444-E447. doi: https://doi.org/10.9778/cmajo.20160062
Goldenberg NM, Steinberg BE, Rutka JT, Chen R, Cabral V, Rosenblum ND, Kapus A, Lee WL. Research projects in the Surgeon-Scientist and Clinician-Investigator programs at the University of Toronto (1987-2016): a cohort study. CMAJ Open. 2016 Aug 22;4(3):E444-E447. doi: 10.9778/cmajo.20160062. eCollection 2016. PMID: 27730108; PMCID: PMC5047840.
Copy Download .nbib Format: NLM
A phase II study of TRC105 in patients with hepatocellular carcinoma who have progressed on sorafenib.

United European gastroenterology journal

Duffy AG, Ulahannan SV, Cao L, Rahma OE, Makarova-Rusher OV, Kleiner DE, Fioravanti S, Walker M, Carey S, Yu Y, Venkatesan AM, Turkbey B, Choyke P, Trepel J, Bollen KC, Steinberg SM, Figg WD, Greten TF.
PMID: 26535124
United European Gastroenterol J. 2015 Oct;3(5):453-61. doi: 10.1177/2050640615583587.

BACKGROUND: Endoglin is an endothelial cell membrane receptor essential for angiogenesis and highly expressed on the vasculature of many tumor types, including hepatocellular carcinoma (HCC). TRC105 is a chimeric IgG1 anti-CD105 monoclonal antibody that inhibits angiogenesis and tumor growth...

Cite
Duffy AG, Ulahannan SV, Cao L, et al. A phase II study of TRC105 in patients with hepatocellular carcinoma who have progressed on sorafenib. United European Gastroenterol J. 2015;3(5):453-61doi: 10.1177/2050640615583587.
Duffy, A. G., Ulahannan, S. V., Cao, L., Rahma, O. E., Makarova-Rusher, O. V., Kleiner, D. E., Fioravanti, S., Walker, M., Carey, S., Yu, Y., Venkatesan, A. M., Turkbey, B., Choyke, P., Trepel, J., Bollen, K. C., Steinberg, S. M., Figg, W. D., & Greten, T. F. (2015). A phase II study of TRC105 in patients with hepatocellular carcinoma who have progressed on sorafenib. United European gastroenterology journal, 3(5), 453-61. https://doi.org/10.1177/2050640615583587
Duffy, A G, et al. "A phase II study of TRC105 in patients with hepatocellular carcinoma who have progressed on sorafenib." United European gastroenterology journal vol. 3,5 (2015): 453-61. doi: https://doi.org/10.1177/2050640615583587
Duffy AG, Ulahannan SV, Cao L, Rahma OE, Makarova-Rusher OV, Kleiner DE, Fioravanti S, Walker M, Carey S, Yu Y, Venkatesan AM, Turkbey B, Choyke P, Trepel J, Bollen KC, Steinberg SM, Figg WD, Greten TF. A phase II study of TRC105 in patients with hepatocellular carcinoma who have progressed on sorafenib. United European Gastroenterol J. 2015 Oct;3(5):453-61. doi: 10.1177/2050640615583587. PMID: 26535124; PMCID: PMC4625750.
Copy Download .nbib Format: NLM
Pre-injury beta blocker use does not affect the hyperdynamic response in older trauma patients.

Journal of emergencies, trauma, and shock

Evans DC, Khoo KM, Radulescu A, Cook CH, Gerlach AT, Papadimos TJ, Steinberg SM, Stawicki SP, Eiferman DS.
PMID: 25400393
J Emerg Trauma Shock. 2014 Oct;7(4):305-9. doi: 10.4103/0974-2700.142766.

PURPOSE: Trauma dogma dictates that the physiologic response to injury is blunted by beta-blockers and other cardiac medications. We sought to determine how the pre-injury cardiac medication profile influences admission physiology and post-injury outcomes.MATERIALS AND METHODS: Trauma patients older...

Cite
Evans DC, Khoo KM, Radulescu A, et al. Pre-injury beta blocker use does not affect the hyperdynamic response in older trauma patients. J Emerg Trauma Shock. 2014;7(4):305-9doi: 10.4103/0974-2700.142766.
Evans, D. C., Khoo, K. M., Radulescu, A., Cook, C. H., Gerlach, A. T., Papadimos, T. J., Steinberg, S. M., Stawicki, S. P., & Eiferman, D. S. (2014). Pre-injury beta blocker use does not affect the hyperdynamic response in older trauma patients. Journal of emergencies, trauma, and shock, 7(4), 305-9. https://doi.org/10.4103/0974-2700.142766
Evans, David C, et al. "Pre-injury beta blocker use does not affect the hyperdynamic response in older trauma patients." Journal of emergencies, trauma, and shock vol. 7,4 (2014): 305-9. doi: https://doi.org/10.4103/0974-2700.142766
Evans DC, Khoo KM, Radulescu A, Cook CH, Gerlach AT, Papadimos TJ, Steinberg SM, Stawicki SP, Eiferman DS. Pre-injury beta blocker use does not affect the hyperdynamic response in older trauma patients. J Emerg Trauma Shock. 2014 Oct;7(4):305-9. doi: 10.4103/0974-2700.142766. PMID: 25400393; PMCID: PMC4231268.
Copy Download .nbib Format: NLM
Identification of active chemotherapy regimens in advanced biliary tract carcinoma: a review of chemotherapy trials in the past two decades.

Hepatic oncology

Ulahannan SV, Rahma OE, Duffy AG, Makarova-Rusher OV, Kurtoglu M, Liewehr DJ, Steinberg SM, Greten TF.
PMID: 25685318
Hepat Oncol. 2015 Jan 01;2(1):39-50. doi: 10.2217/hep.14.36.

Biliary tract carcinoma is a rare malignancy. We performed a comprehensive analysis of published prospective clinical trials in advanced biliary tract carcinoma in an attempt to identify active regimens in this setting. We searched PubMed and abstracts presented at...

Cite
Ulahannan SV, Rahma OE, Duffy AG, et al. Identification of active chemotherapy regimens in advanced biliary tract carcinoma: a review of chemotherapy trials in the past two decades. Hepat Oncol. 2015;2(1):39-50doi: 10.2217/hep.14.36.
Ulahannan, S. V., Rahma, O. E., Duffy, A. G., Makarova-Rusher, O. V., Kurtoglu, M., Liewehr, D. J., Steinberg, S. M., & Greten, T. F. (2015). Identification of active chemotherapy regimens in advanced biliary tract carcinoma: a review of chemotherapy trials in the past two decades. Hepatic oncology, 2(1), 39-50. https://doi.org/10.2217/hep.14.36
Ulahannan, Susanna V, et al. "Identification of active chemotherapy regimens in advanced biliary tract carcinoma: a review of chemotherapy trials in the past two decades." Hepatic oncology vol. 2,1 (2015): 39-50. doi: https://doi.org/10.2217/hep.14.36
Ulahannan SV, Rahma OE, Duffy AG, Makarova-Rusher OV, Kurtoglu M, Liewehr DJ, Steinberg SM, Greten TF. Identification of active chemotherapy regimens in advanced biliary tract carcinoma: a review of chemotherapy trials in the past two decades. Hepat Oncol. 2015 Jan 01;2(1):39-50. doi: 10.2217/hep.14.36. PMID: 25685318; PMCID: PMC4326054.
Copy Download .nbib Format: NLM
Immune Dysregulation in Patients Persistently Infected with Human Papillomaviruses 6 and 11.

Journal of clinical medicine

Lucs AV, DeVoti JA, Hatam L, Afzal A, Abramson AL, Steinberg BM, Bonagura VR.
PMID: 26023354
J Clin Med. 2015 Mar;4(3):375-88. doi: 10.3390/jcm4030375.

Human Papillomaviruses (HPVs) 6 and 11 are part of a large family of small DNA viruses, some of which are commensal. Although much of the population can contain or clear infection with these viruses, there is a subset of...

Cite
Lucs AV, DeVoti JA, Hatam L, et al. Immune Dysregulation in Patients Persistently Infected with Human Papillomaviruses 6 and 11. J Clin Med. 2015;4(3):375-88doi: 10.3390/jcm4030375.
Lucs, A. V., DeVoti, J. A., Hatam, L., Afzal, A., Abramson, A. L., Steinberg, B. M., & Bonagura, V. R. (2015). Immune Dysregulation in Patients Persistently Infected with Human Papillomaviruses 6 and 11. Journal of clinical medicine, 4(3), 375-88. https://doi.org/10.3390/jcm4030375
Lucs, Alexandra V, et al. "Immune Dysregulation in Patients Persistently Infected with Human Papillomaviruses 6 and 11." Journal of clinical medicine vol. 4,3 (2015): 375-88. doi: https://doi.org/10.3390/jcm4030375
Lucs AV, DeVoti JA, Hatam L, Afzal A, Abramson AL, Steinberg BM, Bonagura VR. Immune Dysregulation in Patients Persistently Infected with Human Papillomaviruses 6 and 11. J Clin Med. 2015 Mar;4(3):375-88. doi: 10.3390/jcm4030375. PMID: 26023354; PMCID: PMC4444053.
Copy Download .nbib Format: NLM
Nickel-Catalyzed C-H Arylation of Benzoxazoles and Oxazoles: Benchmarking the Influence of Electronic, Steric and Leaving Group Variations in Phenolic Electrophiles.

Tetrahedron

Steinberg DF, Turk MC, Kalyani D.
PMID: 29051675
Tetrahedron. 2017 Apr 20;73(16):2196-2209. doi: 10.1016/j.tet.2017.02.021. Epub 2017 Feb 14.

No abstract available.

Cite
Steinberg DF, Turk MC, Kalyani D. Nickel-Catalyzed C-H Arylation of Benzoxazoles and Oxazoles: Benchmarking the Influence of Electronic, Steric and Leaving Group Variations in Phenolic Electrophiles. Tetrahedron. 2017;73(16):2196-2209doi: 10.1016/j.tet.2017.02.021.
Steinberg, D. F., Turk, M. C., & Kalyani, D. (2017). Nickel-Catalyzed C-H Arylation of Benzoxazoles and Oxazoles: Benchmarking the Influence of Electronic, Steric and Leaving Group Variations in Phenolic Electrophiles. Tetrahedron, 73(16), 2196-2209. https://doi.org/10.1016/j.tet.2017.02.021
Steinberg, Deborah F, et al. "Nickel-Catalyzed C-H Arylation of Benzoxazoles and Oxazoles: Benchmarking the Influence of Electronic, Steric and Leaving Group Variations in Phenolic Electrophiles." Tetrahedron vol. 73,16 (2017): 2196-2209. doi: https://doi.org/10.1016/j.tet.2017.02.021
Steinberg DF, Turk MC, Kalyani D. Nickel-Catalyzed C-H Arylation of Benzoxazoles and Oxazoles: Benchmarking the Influence of Electronic, Steric and Leaving Group Variations in Phenolic Electrophiles. Tetrahedron. 2017 Apr 20;73(16):2196-2209. doi: 10.1016/j.tet.2017.02.021. Epub 2017 Feb 14. PMID: 29051675; PMCID: PMC5642964.
Copy Download .nbib Format: NLM
Humic Substances Delay Aging of the Photosynthetic Apparatus of Chara hispida.

Journal of phycology

Pörs Y, Steinberg CE.
PMID: 27010001
J Phycol. 2012 Dec;48(6):1522-9. doi: 10.1111/jpy.12012. Epub 2012 Nov 07.

In freshwaters, dissolved humic substances (HSs) distinguish apparently HS-avoiding Charophytes from apparently HS-tolerant ones, but the underlying mechanisms so far remain obscure. In this contribution, we tested direct and indirect effects of HSs on Chara hispida (L.) Hartm. Using...

Cite
Pörs Y, Steinberg CE. Humic Substances Delay Aging of the Photosynthetic Apparatus of Chara hispida. J Phycol. 2012;48(6):1522-9doi: 10.1111/jpy.12012.
Pörs, Y., & Steinberg, C. E. (2012). Humic Substances Delay Aging of the Photosynthetic Apparatus of Chara hispida. Journal of phycology, 48(6), 1522-9. https://doi.org/10.1111/jpy.12012
Pörs, Yvonne, and Steinberg, Christian E W. "Humic Substances Delay Aging of the Photosynthetic Apparatus of Chara hispida." Journal of phycology vol. 48,6 (2012): 1522-9. doi: https://doi.org/10.1111/jpy.12012
Pörs Y, Steinberg CE. Humic Substances Delay Aging of the Photosynthetic Apparatus of Chara hispida. J Phycol. 2012 Dec;48(6):1522-9. doi: 10.1111/jpy.12012. Epub 2012 Nov 07. PMID: 27010001.
Copy Download .nbib Format: NLM
Mechanisms for redox-regulation of protein kinase C.

Frontiers in pharmacology

Steinberg SF.
PMID: 26157389
Front Pharmacol. 2015 Jun 23;6:128. doi: 10.3389/fphar.2015.00128. eCollection 2015.

Protein kinase C (PKC) is comprised of a family of signal-regulated enzymes that play pleiotropic roles in the control of many physiological and pathological responses. PKC isoforms are traditionally viewed as allosterically activated enzymes that are recruited to membranes...

Cite
Steinberg SF. Mechanisms for redox-regulation of protein kinase C. Front Pharmacol. 2015;6:128doi: 10.3389/fphar.2015.00128.
Steinberg, S. F. (2015). Mechanisms for redox-regulation of protein kinase C. Frontiers in pharmacology, 6128. https://doi.org/10.3389/fphar.2015.00128
Steinberg, Susan F. "Mechanisms for redox-regulation of protein kinase C." Frontiers in pharmacology vol. 6 (2015): 128. doi: https://doi.org/10.3389/fphar.2015.00128
Steinberg SF. Mechanisms for redox-regulation of protein kinase C. Front Pharmacol. 2015 Jun 23;6:128. doi: 10.3389/fphar.2015.00128. eCollection 2015. PMID: 26157389; PMCID: PMC4477140.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 350 entries